﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Obstetrics and Gynecology International</title><link>http://www.hindawi.com</link><description>The latest articles from Hindawi Publishing Corporation</description><copyright>&amp;#169; 2012, Hindawi Publishing Corporation. All rights reserved.</copyright><item><title>Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity</title><link>http://www.hindawi.com/journals/ogi/2012/306347/</link><description>Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disturbances in women of reproductive age. Besides its well-known effects on reproductive health, it is also linked to increased cardiovascular risk in later life. The aim of this study is to investigate some classical cardiovascular risk factors in a crossectional study of Bulgarian women with PCOS and/or obesity. We performed a retrospective medical chart review of 375 women from an university endocrine clinic. We found significant differences in the indices of carbohydrate metabolism, blood pressure, lipid profile, rate of liver steatosis, and the levels liver enzymes and hematological results between the lean and obese PCOS women. Obese women without PCOS did not show significantly different results in their OGGT form obese PCOS women. Waist-to-stature-ratio (WSR) correlated better with the baseline IRI levels and lipid profile than waist-to-hip-ratio (WHR) that makes it a better marker for unfavorable metabolic profile.</description><Author>Antoaneta Gateva and Zdravko Kamenov</Author><copyright>Copyright &amp;#xa9; 2012 Antoaneta Gateva and Zdravko Kamenov. All rights reserved.</copyright></item><item><title>Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin</title><link>http://www.hindawi.com/journals/ogi/2011/548327/</link><description>Objectives. To compare the effectiveness of postcesarean thromboprophylaxis with two different regimens of bemiparin. Material and Methods. The study included 646 women with cesarean delivery in our hospital within a 1-year period, randomly assigned to one of two groups for prophylaxis with 3500&amp;#x2009;IU bemiparin once daily for 5 days or 3500&amp;#x2009;IU bemiparin once daily for 10 days. Results. There was one case of pulmonary embolism (first day following cesarean). An additional risk factor was present in 98.52&amp;#37; of the women, most frequently emergency cesarean, anemia, or obesity. The only risk factors for thromboembolic disease significantly related to pulmonary thromboembolism were placental abruption and prematurity. There were no differences in thromboembolic events among the two thromboprophylaxis regimens. Conclusions. Cesarean-related thromboembolic events were reduced in our study population due to the thromboprophylactic measures taken. Thromboprophylaxis with 3500&amp;#x2009;IU bemiparin once daily for 5 days following cesarean was sufficient to avoid thromboembolic events.</description><Author>Milagros Cruz, Ana M. Fernández-Alonso, Isabel Rodríguez, Loreto Garrigosa, Africa Caño, Pilar Carretero, Amelia Vizca&amp;#237;no, and Amanda Rocío Gonzalez-Ramirez</Author><copyright>Copyright &amp;#xa9; 2011 Milagros Cruz et al. All rights reserved.</copyright></item><item><title>Polycystic Diseases in Visceral Organs</title><link>http://www.hindawi.com/journals/ogi/2011/609370/</link><description>Primary cilia are nonmotile, microtubule-based, antenna-like organelles projecting from the apical surface of most mammalian cells. Elegant studies have established the importance of ciliary structure and function in signal transduction and the sensory roles of cilia in maintaining healthy cellular state. In particular, dysfunctional cilia have been implicated in a large number of diseases mainly characterized by the presence of fluid-filled cysts in various organs. Aside from polycystic kidney disease (PKD), however, the roles of cilia in polycystic liver disease (PLD), polycystic pancreas disease (PPD), and polycystic ovarian syndrome (PCOS) are still very vague. In addition, although gender and sex hormones are known to regulate cyst formation, their roles in regulating physiological functions of cilia need to be further explored.</description><Author>Shakila Abdul-Majeed and Surya M. Nauli</Author><copyright>Copyright &amp;#xa9; 2011 Shakila Abdul-Majeed and Surya M. Nauli. All rights reserved.</copyright></item><item><title>Endometriosis Gene Expression Heterogeneity and Biosignature: A Phylogenetic Analysis</title><link>http://www.hindawi.com/journals/ogi/2011/719059/</link><description>Endometriosis is a multifactorial disease with poorly understood etiology, and reflecting an evolutionary nature where genetic alterations accumulate throughout pathogenesis. Our objective was to characterize the heterogeneous pathological process using parsimony phylogenetics. Gene expression microarray data of ovarian endometriosis obtained from NCBI database were polarized and coded into derived (abnormal) and ancestral (normal) states. Such alterations are referred to as synapomorphies in a phylogenetic sense (or biomarkers). Subsequent gene linkage was modeled by Genomatix BiblioSphere Pathway software. A list of clonally shared derived (abnormal) expressions revealed the pattern of heterogeneity among specimens. In addition, it has identified disruptions within the major regulatory pathways including those involved in cell proliferation, steroidogenesis, angiogenesis, cytoskeletal organization and integrity, and tumorigenesis, as well as cell adhesion and migration. Furthermore, the analysis supported the potential central involvement of ESR2 in the initiation of endometriosis. The pathogenesis mapping showed that eutopic and ectopic lesions have different molecular biosignatures.</description><Author>Mones Abu-Asab, Ming Zhang, Dennis Amini, Nihad Abu-Asab, and Hakima Amri</Author><copyright>Copyright &amp;#xa9; 2011 Mones Abu-Asab et al. All rights reserved.</copyright></item><item><title>Robotic Surgery in Gynecology: An Updated Systematic Review</title><link>http://www.hindawi.com/journals/ogi/2011/852061/</link><description>The introduction of da Vinci Robotic Surgery to the field of Gynecology has resulted in large changes in surgical management.  The robotic platform allows less experienced laparoscopic surgeons to perform more complex procedures. In general gynecology and reproductive gynecology, the robot is being increasingly used for procedures such as hysterectomies, myomectomies, adnexal surgery, and tubal anastomosis. Among urogynecology the robot is being utilized for sacrocolopexies.  In the field of gynecologic oncology, the robot is being increasingly used for hysterectomies and lymphadenectomies in oncologic diseases. Despite the rapid and widespread adoption of robotic surgery in gynecology, there are no randomized trials comparing its efficacy and safety to other traditional surgical approaches.  Our aim is to update previously published reviews with a focus on only comparative observational studies.  We determined that, with the right amount of training and skill, along with appropriate patient selection, robotic surgery can be highly advantageous.  Patients will likely have less blood loss, less post-operative pain, faster recoveries, and fewer complications compared to open surgery and potentially even laparoscopy.  However, until larger, well-designed observational studies or randomized control trials are completed which report long-term outcomes, we cannot definitively state the superiority of robotic surgery over other surgical methods.</description><Author>Lori Weinberg, Sanjay Rao, and Pedro F. Escobar</Author><copyright>Copyright &amp;#xa9; 2011 Lori Weinberg et al. All rights reserved.</copyright></item><item><title>Robotic Surgery in Gynecologic Oncology</title><link>http://www.hindawi.com/journals/ogi/2011/139867/</link><description>Robotic surgery for the management of gynecologic cancers allows for minimally invasive surgical removal of cancer-bearing organs and tissues using sophisticated surgeon-manipulated, robotic surgical instrumentation. Early on, gynecologic oncologists recognized that minimally invasive surgery was associated with less surgical morbidity and that it shortened postoperative recovery. Now, robotic surgery represents an effective alternative to conventional laparotomy. Since its widespread adoption, minimally invasive surgery has become an option not only for the morbidly obese but for women with gynecologic malignancy where conventional laparotomy has been associated with significant morbidity. As such, this paper considers indications for robotic surgery, reflects on outcomes from initial robotic surgical outcomes data, reviews cost efficacy and implications in surgical training, and discusses new roles for robotic surgery in gynecologic cancer management.</description><Author>Robert DeBernardo, David Starks, Nichole Barker, Amy Armstrong, and Charles A. Kunos</Author><copyright>Copyright &amp;#xa9; 2011 Robert DeBernardo et al. All rights reserved.</copyright></item><item><title>The Feasibility of Societal Cost Equivalence between Robotic Hysterectomy and Alternate Hysterectomy Methods for Endometrial Cancer</title><link>http://www.hindawi.com/journals/ogi/2011/570464/</link><description>Objectives. We assess whether it is feasible for robotic hysterectomy for endometrial cancer to be less expensive to society than traditional laparoscopic hysterectomy or abdominal hysterectomy. Methods. We performed a retrospective cohort analysis of patient characteristics, operative times, complications, and hospital charges from all (n=234) endometrial cancer patients who underwent hysterectomy in 2009 at our hospital. Per patient costs of each hysterectomy method were examined from the societal perspective. Sensitivity analysis and Monte Carlo simulation were performed using a cost-minimization model. Results. 40 (17.1%) of hysterectomies for endometrial cancer were robotic, 91 (38.9%), were abdominal, and 103 (44.0%) were laparoscopic. 96.3% of the variation in operative cost between patients was predicted by operative time (R=0.963, P&amp;#x0003c;0.01). Mean operative time for robotic hysterectomy was significantly longer than other methods (P&amp;#x0003c;0.01). Abdominal hysterectomy was consistently the most expensive while the traditional laparoscopic approach was consistently least expensive. The threshold in operative time that makes robotic hysterectomy cost equivalent to the abdominal approach is within the range of our experience. Conclusion. It is feasible for robotic hysterectomy to be less expensive than abdominal hysterectomy, but unlikely for robotic hysterectomy to be less expensive than traditional laparoscopy.</description><Author>Neel T. Shah, Kelly N. Wright, Gudrun M. Jonsdottir, Selena Jorgensen, Jon I. Einarsson, and Michael G. Muto</Author><copyright>Copyright &amp;#xa9; 2011 Neel T. Shah et al. All rights reserved.</copyright></item><item><title>Effect of Red Clover Isoflavones over Skin, Appendages, and  Mucosal Status in Postmenopausal Women</title><link>http://www.hindawi.com/journals/ogi/2011/949302/</link><description> Objective. Evaluate in postmenopausal women the effect of red clover extract (RCE) isoflavones over subjective status of skin, appendages, and several mucosal sites. Method. Postmenopausal women (n=109) were randomly assigned to receive either two daily capsules of the active compound (80&amp;#x02009;mg RCE, Group A) or placebo of equal appearance (Group B) for a 90-day period. After a washout period of 7 days, medication was crossed over and taken for 90 days more. Subjective improvement of skin, appendages, and several mucosal site status was assessed for each studied group at 90 and 187 days using a visual analogue scale (VAS). In addition, libido, tiredness, and urinary, sleep, and mood complaints were also evaluated. Results. Women after RCE intervention (both groups) reported better subjective improvement of scalp hair and skin status, libido, mood, sleep, and tiredness. Improvement of urinary complaints, nail, body hair, and mucosa (oral, nasal, and ocular) status did not differ between treatment phases (intra- and intergroup). Overall satisfaction with treatment was reported higher after RCE intervention (both groups) as compared to placebo. Conclusion. RCE supplementation exerted a subject improvement of scalp hair and skin status as well as libido, mood, sleep, and tiredness in postmenopausal women.</description><Author>Markus Lipovac, Peter Chedraui, Christine Gruenhut, Anca Gocan, Christine Kurz, Benedikt Neuber, and Martin Imhof</Author><copyright>Copyright &amp;#xa9; 2011 Markus Lipovac et al. All rights reserved.</copyright></item><item><title>Comparison of Perioperative Outcomes of Total Laparoscopic and Robotically Assisted Hysterectomy for Benign Pathology during Introduction of a Robotic Program</title><link>http://www.hindawi.com/journals/ogi/2011/683703/</link><description>Study Objective. Prospectively compare outcomes of robotically assisted and laparoscopic hysterectomy in the process of implementing a new robotic program. Design. Prospectively comparative observational nonrandomized study. Design Classification. II-1. Setting. Tertiary caregiver university hospital. Patients. Data collected consecutively  24 months, 34 patients underwent laparoscopic hysterectomy, 25 patients underwent robotic hysterectomy, and 11 patients underwent vaginal hysterectomy at our institution. Interventions. Outcomes of robotically assisted, laparoscopic, and vaginal complex hysterectomies performed by a single surgeon for noncancerous indications. Measurements and Main Results. Operative times were 208.3&amp;#x00B1;59.01 minutes for laparoscopic, 286.2 &amp;#x00B1; 82.87 minutes for robotic, and 163.5 &amp;#x00B1; 61.89 minutes for vaginal (P&amp;#x003C;.0001). Estimated blood loss for patients undergoing laparoscopic surgery was 242.7&amp;#x00B1;211.37&amp;#x2009;cc, 137.4&amp;#x00B1;107.50&amp;#x2009;cc for robotic surgery, and 243.2&amp;#x00B1;127.52&amp;#x2009;cc for vaginal surgery (P=0.05). The mean length of stay ranged from 1.8 to 2.3 days for the 3 methods. Association was significant for uterine weight (P=0.0043) among surgery methods. Conclusion. Robotically assisted hysterectomy is feasible with low morbidity, a shorter hospital stay, and less blood loss. This suggests that robotic assistance facilitates a minimally invasive approach for patients with larger uterine size even during implementing a new robotic program.</description><Author>Gokhan Sami Kilic, Gradie Moore, Ayman Elbatanony, Carmen Radecki, John Y. Phelps, and Mostafa A. Borahay</Author><copyright>Copyright &amp;#xa9; 2011 Gokhan Sami Kilic et al. All rights reserved.</copyright></item><item><title>Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011</title><link>http://www.hindawi.com/journals/ogi/2012/921236/</link><description>Objectives. A 
                  systematic review of parental surveys about HPV 
                  and/or child HPV vaccination to understand 
                  parental knowledge, attitudes, and behaviour 
                  before and after FDA approval of the 
                  quadrivalent HPV vaccine and the bivalent HPV 
                  vaccine. Search Strategy. 
                  Searches were conducted using electronic 
                  databases limited to published studies between 
                  2001 and 2011. Findings. The 
                  percentage of parents who heard about HPV rose 
                  over time (from 60&amp;#37; in 2005 to 93&amp;#37; in 
                  2009), as did their appreciation for the HPV 
                  infection and cervical cancer link (from 70&amp;#37; in 
                  2003 to 91&amp;#37; in 2011). During the FDA 
                  approval, there was a stronger vaccine awareness 
                  but it has waned. The same pattern is seen with 
                  parents whose children received the HPV vaccine 
                  (peak at 84&amp;#37; in 2010 and now 36&amp;#37; in 
                  2011) or the intention to vaccinate (peak at 
                  80&amp;#37; in 2008 and now 41&amp;#37; in 2011). 
                  Conclusions. Parents had safety 
                  concerns and wanted more information their 
                  physician from to recommend and to confidently HPV 
                  vaccinate their children.</description><Author>Kristina Trim, Naushin Nagji, Laurie Elit, and Katherine Roy</Author><copyright>Copyright &amp;#xa9; 2012 Kristina Trim et al. All rights reserved.</copyright></item><item><title>The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy</title><link>http://www.hindawi.com/journals/ogi/2011/547946/</link><description>After an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most cost-effective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropriate way to conceive future pregnancies. Methods. Between 1998 and 2008, 144 patients were submitted to medical treatment for an EP and performed HSG 3 months after the event. Results. 72.2&amp;#37; of normal HSG, 18.8&amp;#37; with unilateral obstruction, 6.3&amp;#37; tubal patency with defect, and 2.8&amp;#37; bilateral obstruction. Conclusion. Routine HSG following medical treatment for an EP does not seem necessary, as it does not change the initial management in 97.2&amp;#37; of the cases, but might be considered in selected risk cases, permitting timely referral of patients to in vitro fertilization.</description><Author>Emma Garcia Grau, Miguel &amp;#193;ngel Checa Vizca&amp;#237;no, M&amp;#225;rio Oliveira, Judith Lleberia Juan&amp;#243;s, Ramon Carreras Collado, and Yolanda Canet Estevez</Author><copyright>Copyright &amp;#xa9; 2011 Emma Garcia Grau et al. All rights reserved.</copyright></item><item><title>Comparison of Nulliparas Undergoing Cesarean Section in First and Second Stages of Labour: A Prospective Study in a Tertiary Teaching Hospital</title><link>http://www.hindawi.com/journals/ogi/2011/986506/</link><description>Objective. We performed a prospective observational audit study to compare neonatal and maternal outcomes of the primary cesarean sections performed in first stage versus second stage of labour. Methods. One thousand three hundred and eighty-nine nullipara women who had undergone cesarean section in a tertiary teaching hospital between February 1, 2009 and January 31, 2010 were included in the study. Primary maternal outcomes of interest were uterine atonia, transfusion requirement, urinary system injury, requirement for hysterectomy, and duration of hospital stay. Results. A total of 1389 women underwent cesarean section at this 12 month time period. Of these 1389 cesarean sections, 1271 were in the first stage of the labour and 171 were in the second stage of the labour. Urinary injuries, transfusion requirement, and uterine atonia hysterectomy were significantly more frequent in women who underwent cesarean section in the second stage of the labour compared to women undergoing cesarean section in the first stage of the labour. Conclusion. Cesarean section in the second stage of the labour is associated with increased maternal and neonatal morbidities. Special attention is required to the patients undergoing cesarean section in the second stage of the labour.</description><Author>Ayhan Sucak, &amp;#350;evki &amp;#199;elen, Eren Akbaba, Sunullah Soysal, Ozlem Moraloglu, and Nuri Dan&amp;#x131;&amp;#351;man</Author><copyright>Copyright &amp;#xa9; 2011 Ayhan Sucak et al. All rights reserved.</copyright></item><item><title>Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?</title><link>http://www.hindawi.com/journals/ogi/2011/973830/</link><description>The exponential use of robotic surgery is not the result of evidence-based benefits but mainly driven by the manufacturers, patients and enthusiastic surgeons. The present review of the literature shows that robot-assisted surgery is consistently more expensive than video-laparoscopy and in many cases open surgery. The average additional variable cost for gynecological procedures  was about 1600&amp;#x2009;USD, rising to more than 3000&amp;#x2009;USD when the amortized cost of the robot itself was included. Generally most robotic and laparoscopic procedures have less short-term morbidity, blood loss, intensive care unit, and hospital stay than open surgery. Up to now no major consistent differences have been found between robot-assisted and classic video-assisted procedures for these factors. No comparative data are available on long-term morbidity and oncologic outcome after open, robotic, and laparoscopic gynecologic surgery. It seems that currently only for very complex surgical procedures, such as cardiac surgery, the costs of robotics can be competitive to open surgical procedures. In order to stay viable, robotic programs will need to pay for themselves on a per case basis and the costs of robotic surgery will have to be reduced.</description><Author>Peter van Dam, Jan Hauspy, Luc Verkinderen, Xuan Bich Trinh, Pieter-Jan van Dam, Luc Van Looy, and Luc Dirix</Author><copyright>Copyright &amp;#xa9; 2011 Peter van Dam et al. All rights reserved.</copyright></item><item><title>Pathways of Metastases from Primary Organs to the Ovaries</title><link>http://www.hindawi.com/journals/ogi/2011/612817/</link><description>To investigate the metastatic pathways from the primary organs to the ovaries, we examined the microscopic findings from 18 original and 18 metastatic ovarian tumors carefully. In addition, we examined the immunohistochemical findings (Victoria blue stain for vascular invasion and D2-40 expression for lymphangio invasion) of metastatic ovarian tumors carefully. There were 4 (57%) ovarian lymphangio invasion cases in the 7 gastric cancers, but there were no cases in the 6 colorectal cancers (P &amp;#60; 0.05). There were 4 (67%) ovarian vascular invasion cases and one (17%) liver metastasis case in the 6 colorectal cancers, while there were no ovarian vascular invasions (P &amp;#60; 0.05) or no liver metastases in the 7 gastric cancers. The patients with metastatic ovarian tumors originating from distant organs who were treated at the same time as the original cancers had a significantly poorer prognosis than the patients with ovarian tumors treated later (P &amp;#60; 0.05). The rate of lymphatic metastasis from the stomach to the ovary was significantly higher than from the colon to the ovary. In addition we hypothesized that the rate of intravascular metastasis from the colorectum to the ovary was relatively higher than from the stomach to the ovary.</description><Author>Yukio Yamanishi, Masafumi Koshiyama, Megumi Ohnaka, Masashi Ueda, Shingo Ukita, Kenji Hishikawa, Michikazu Nagura, Tomoko Kim, Masaya Hirose, Hiroshi Ozasa, and Tomoyuki Shirase</Author><copyright>Copyright &amp;#xa9; 2011 Yukio Yamanishi et al. All rights reserved.</copyright></item><item><title>Blocking Epidermal Growth Factor Receptor Signaling in HTR-8/SVneo First Trimester Trophoblast Cells Results in Dephosphorylation of PKB&amp;#x03B1;/AKT and Induces Apoptosis</title><link>http://www.hindawi.com/journals/ogi/2011/896896/</link><description>We identified a major peptide signaling target of EGF/EGFR pathway and explored the consequences of blocking or activating this pathway in the first trimester extravillous trophoblast cells, HTR-8/SVneo. A global analysis of protein phosphorylation was undertaken using novel technology (Kinexus Kinetworks) that utilizes SDS-polyacrylamide minigel electrophoresis and multi-lane immunoblotting to permit specific and semiquantitative detection of multiple phosphoproteins. Forty-seven protein phosphorylation sites were queried, and the results reported based on relative phosphorylation at each site. EGF- and Iressa-(gefitinib, ZD1839, an inhibitor of EGFR) treated HTR-8/SVneo cells were subjected to immunoblotting and flow cytometry to confirm the phosphoprotein screen and to assess the effects of EGF versus Iressa on cell cycle and apoptosis. EGFR mediates the phosphorylation of important signaling proteins, including PKB&amp;#x3b1;/AKT. This pathway is likely to be central to EGFR-mediated trophoblast survival. Furthermore, EGF treatment induces proliferation and inhibits apoptosis, while Iressa induces apoptosis.</description><Author>J. Bolnick, L. Albitar, L. L. Laidler, R. Abdullah, and K. K. Leslie</Author><copyright>Copyright &amp;#xa9; 2011 J. Bolnick et al. All rights reserved.</copyright></item><item><title>Fluid Retention over the Menstrual Cycle: 1-Year Data from the Prospective Ovulation Cohort</title><link>http://www.hindawi.com/journals/ogi/2011/138451/</link><description>We report menstrual and mid-cycle patterns of self-reported &amp;#8220;fluid retention&amp;#8221; in 765 menstrual cycles in 62 healthy women. Self-reported &amp;#8220;fluid retention,&amp;#8221; commonly described as bloating, is one element of the clinical assessment and diagnosis of premenstrual symptoms. These daily diary data were collected as part of an observational prospective one-year study of bone changes in healthy women of differing exercise characteristics. Ovulation was documented by quantitative basal temperature analysis, and serum estradiol and progesterone levels were available from initial and final cycles. Fluid retention scores (on a 0&amp;#8211;4 scale) peaked on the first day of menstrual flow (mean &amp;#x00B1; SE : 0.9&amp;#x00B1;0.1), were lowest during the mid-follicular period, and gradually increased from 0.22&amp;#x00B1;0.05 to 0.50&amp;#x00B1;0.09 over the 11 days surrounding ovulation. Mid-cycle, but not premenstrual, fluid scores tended to be lower in anovulatory cycles (ANOVA P=0.065), and scores were higher around menstruation than at midcycle (P&amp;#x003C;0.0001). Neither estradiol nor progesterone levels were significantly associated with fluid retention scores. The peak day of average fluid retention was the first day of flow. There were no significant differences in women&amp;#39;s self-perceived fluid retention between ovulatory and anovulatory cycles.</description><Author>Colin P. White, Christine L. Hitchcock, Yvette M. Vigna, and Jerilynn C. Prior</Author><copyright>Copyright &amp;#xa9; 2011 Colin P. White et al. All rights reserved.</copyright></item><item><title>Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon</title><link>http://www.hindawi.com/journals/ogi/2011/143506/</link><description>Objective. To describe the profile of breast cancer in the patients attending the radiation therapy unit of Yaounde General Hospital. Method. From 1989 to 2009, we conducted a descriptive retrospective study based on the register and medical records of patients. Results. During the study period, 531 breast cancer patients were recorded of which 0.75&amp;#x25; were male. Age range was 18 to 82 years, with a mean of 45.17 years. Out of these, 66.1&amp;#x25; were less than 50 years old and 31.9&amp;#x25; less than 40. Self detection was the discovery method in most cases (95.34&amp;#x25; of patients). Mean delay before presentation at hospital was 10.35 months, and 54.94&amp;#x25; had used traditional medicine before medical evaluation. Metastasis and locally advanced breast cancer at diagnosis were present in 08.13&amp;#x25; and 62.78&amp;#x25;, respectively. Mastectomy was used in 88.08&amp;#x25; of patients. Conclusion. The study reinforces the position occupied by late presentation and advanced stage at diagnosis of breast cancer profile in developing countries.</description><Author>J. D. Kemfang Ngowa, J. Yomi, J. M. Kasia, Y. Mawamba, A. C. Ekortarh, and G. Vlastos</Author><copyright>Copyright &amp;#xa9; 2011 J. D. Kemfang Ngowa et al. All rights reserved.</copyright></item><item><title>Ovarian Epithelial-Stromal Interactions: Role of Interleukins 1 and 6</title><link>http://www.hindawi.com/journals/ogi/2011/358493/</link><description>Ovarian epithelial cancer is the most lethal gynecologic malignancy. The high mortality is attributed to the fact that most cases typically present in late stage when ovarian cancer (OC) has already spread beyond the ovary. Ovarian epithelial cancer cells are shed into intraperitoneal ascites and easily disseminate throughout the peritoneal cavity with preferential metastasis to the omentum, peritoneum, and local organs. Understanding how ovarian epithelial cells interact with and modulate their microenvironment can provide insight into the molecular mechanism(s) involved with malignant transformation and progression which may eventually identify novel diagnostic, prognostic, and therapeutic targets. The objective of this paper is to provide a brief consideration of ovarian surface epithelial-stromal interactions in regard to normal physiological function and tumor progression as influenced by two potentially key interleukins, interleukins-1 (IL-1) and -6 (IL-6), present in the microenvironment. Lastly, we will consider the clinical implications of IL-1 and IL-6 for OC patients.</description><Author>Kamisha T. Woolery and Patricia A. Kruk</Author><copyright>Copyright &amp;#xa9; 2011 Kamisha T. Woolery and Patricia A. Kruk. All rights reserved.</copyright></item><item><title>Obesity and the Incidence of Bladder Injury and Urinary Retention Following Tension-Free Vaginal Tape Procedure: Retrospective Cohort Study</title><link>http://www.hindawi.com/journals/ogi/2011/746393/</link><description>Background/Aims. Aim of the study was to establish an effect of obesity on the incidence of bladder injury or urinary retention following tension-free vaginal tape (TVT) procedure. Methods. This was a retrospective cohort study based at the Norfolk and Norwich University Hospital in the UK. Study population included 342 cases of TVT procedures. Incidence of bladder injury was 4.7&amp;#37; (16/342). Rate of urinary retention was 9&amp;#37; (31/342). Body mass index (BMI), age, type of analgesia, concomitant prolapse repair, and previous surgery were factors studied. Univariate analysis was performed to establish a relationship between BMI and complications, followed by a multivariable regression analysis to adjust for age, concomitant surgery, type of analgesia, and previous surgery. Results. Neither univariate analysis nor multivariate regression analysis revealed any statistically significant influence of obesity on the incidence of bladder injury or urinary retention. Unadjusted odds ratios and adjusted odds ratios for bladder injury and urinary retention by BMI groups were OR 1.7296 CI 0.4818&amp;#8211;6.2097; OR 1.3745 CI 0.5718&amp;#8211;3.3043 and adj. OR 2.885 CI 0.603&amp;#8211;13.8; adj. OR 1.299 CI 0.502&amp;#8211;3.365. Conclusion. Obesity does not appear to influence the rate of bladder injury or urinary retention following TVT procedure.</description><Author>Vladimir Revicky, Sambit Mukhopadhyay, Frances de Boer, and Edward P. Morris</Author><copyright>Copyright &amp;#xa9; 2011 Vladimir Revicky et al. All rights reserved.</copyright></item><item><title>Pregnancy and Delivery in Ehlers-Danlos Syndrome (Hypermobility Type): Review of the Literature</title><link>http://www.hindawi.com/journals/ogi/2011/306413/</link><description>Ehlers-Danlos syndrome (EDS) is a group of connective tissue disorders which are divided into various distinguishable phenotypes. The type of EDS determines the potential obstetric complications. Due to the spectrum of clinical manifestation and overlap between phenotypes, there are no standardised obstetric management guidelines. Existing literature illustrates different obstetric management in hypermobility type of EDS, including uneventful term vaginal deliveries as well as preterm cesarean section deliveries. This paper discusses obstetric management of a woman with EDS hypermobility type. Cesarean section was deemed the most appropriate delivery method in this patient due to the possible complications including risk of joint dislocation and pain morbidity. No obstetric complications were experienced, and good maternal and neonatal outcomes were achieved.</description><Author>Indranil Dutta, Helen Wilson, and Odiri Oteri</Author><copyright>Copyright &amp;#xa9; 2011 Indranil Dutta et al. All rights reserved.</copyright></item><item><title>Association of Inherited Thrombophilia with Recurrent Pregnancy Loss in Palestinian Women</title><link>http://www.hindawi.com/journals/ogi/2011/689684/</link><description>Objective. This study aimed at analyzing the association between recurrent pregnancy loss (RPL) and factor V G1691A (FVL), prothrombin G20210 (FII); and MTHFR C677T (MTHFR) in Palestinian women. Method. We studied 329 Palestinian women with RPL and/or stillbirth (SB); and compared them to 402 healthy reproductive Palestinian women. Cases and controls were tested for the above mutations.  Odds ratio (OR) at confidence interval (CI) of 95&amp;#37; was used as a measure of association between the mutations and RPL. Results. Our statistical analysis showed a slightly increased association, which was not significant between FVL and RPL (OR&amp;#x2009;1.32, 95&amp;#37;&amp;#x2009;CI&amp;#x2009;0.90&amp;#8211;1.94), and no association between FII (OR&amp;#x2009;0.84, 95&amp;#37;&amp;#x2009;CI&amp;#x2009;0.38&amp;#8211;1.92), MTHFR (OR&amp;#x2009;0.58, 95&amp;#37; CI&amp;#x2009;0.32&amp;#8211;1.03), and RPL. Further analysis of RPL subgroups revealed an association between FVL and first-trimester loss (OR&amp;#x2009;1.33, 95&amp;#37;&amp;#x2009;CI&amp;#x2009;0.892&amp;#8211;1.989), and second-trimester loss (OR&amp;#x2009;1.13, 95&amp;#37;&amp;#x2009;CI&amp;#x2009;0.480&amp;#8211;2.426), both were not statistically significant.  Furthermore, the only statistically significant association was between FVL and SB (OR&amp;#x2009;2.0, 95&amp;#37;&amp;#x2009;CI&amp;#x2009;1.05&amp;#8211;3.70). Conclusion. Our analysis had failed to find a significant association between FVL, FII, MTHFR; and RPL in either the first or second trimester. FVL was significantly associated with fetal loss if the loss was a stillbirth.</description><Author>N. S. Abu-Asab, S. K. Ayesh, R. O. Ateeq, S. M. Nassar, and W. A. EL-Sharif</Author><copyright>Copyright &amp;#xa9; 2011 N. S. Abu-Asab et al. All rights reserved.</copyright></item><item><title>Antenatal Ultrasonographic Anteroposterior Renal Pelvis Diameter Measurement: Is It a Reliable Way of Defining Fetal Hydronephrosis?</title><link>http://www.hindawi.com/journals/ogi/2011/861865/</link><description>Purpose. It was to quantify the intraobserver and interobserver variability of the sonographic measurements of renal pelvis and classify hydronephrosis severity. Methods. Two ultrasonographers evaluated 17 fetuses from 23 to 39 weeks of gestation. Renal pelvis APD were taken in 50 renal units. For intraobserver error, one of them performed three sequential measurements. The mean and standard deviation from the absolute and percentage differences between measurements were calculated. Bland-Altman plots were used to visually assess the relationship between the precision of repeated measurements. Hydronephrosis was classified as mild (5.0 to 9.9&amp;#x2009;mm), moderate (10.0 to 14.9&amp;#x2009;mm), or severe (&amp;#x2265;15.0&amp;#x2009;mm). Interrater agreement were obtained using the Kappa index.
Results. Absolute intraobserver variation in APD measurements was 5.2&amp;#x00B1;3.5%. Interobserver variation of ultrasonographers was 9.3&amp;#x00B1;9.7%. Neither intraobserver or interobserver error increased with increasing APD size. The overall percentage of agreement with the antenatal hydronephrosis diagnosis was 64%. Cohen's Kappa to hydronephrosis severity was 0.51 (95% CI, 0.33 to 0.69).
Conclusion. Inter and intraobserver APD measurement errors were low in these group, but the agreement to hydronephrosis diagnosis and classification was fair. We suggest that standard and serial APD measurement can better define and evaluate fetal hydronephrosis.</description><Author>Alamanda Kfoury Pereira, Zilma Silveira Nogueira Reis, Maria C&amp;#226;ndida Ferrarez Bouzada, Eduardo Ara&amp;#250;jo de Oliveira, Gabriel Osanan, and Ant&amp;#244;nio Carlos Vieira Cabral</Author><copyright>Copyright &amp;#xa9; 2011 Alamanda Kfoury Pereira et al. All rights reserved.</copyright></item><item><title>Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report</title><link>http://www.hindawi.com/journals/ogi/2011/698648/</link><description>Background. Alpha II antiplasmin is a protein involved in the inhibition of fibrinolysis. A deficiency in this protein leads to increased hemorrhage. It is inherited in an autosomal recessive fashion. Case. 30-year-old Gravida 1, Para 0, presented for prenatal care with her first and subsequently her second pregnancy. Her medical history was significant for a known deficiency in alpha II antiplasmin. Her first and second pregnancies were complicated by nonobstetrical hemorrhage requiring transfusions and severe preeclampsia requiring preterm deliveries.
Conclusion. Alpha II antiplasmin deficiency resulted in multiple episodes of nonobstetrical hemorrhages requiring transfusion and ultimately preterm deliveries due to severe preeclampsia.
Both infants and mother had a good outcome. The presence of this disorder may require a multidisciplinary team approach involving obstetricians, pediatricians, and hematologists. Precis. Alpha II antiplasmin deficiency is a rare autosomal recessive disorder leading to increased fibrinolysis and hemorrhage. We present a case report of a pregnancy complicated by this disorder.</description><Author>Brenda Dawley</Author><copyright>Copyright &amp;#xa9; 2011 Brenda Dawley. All rights reserved.</copyright></item><item><title>Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only</title><link>http://www.hindawi.com/journals/ogi/2011/962518/</link><description>Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma.
Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2&amp;#37; for adnexal involvement and 16.0&amp;#37; for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7&amp;#37; for adnexal involvement and 58.7&amp;#37; for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8&amp;#37; for patients with adnexal involvement and 75.4&amp;#37; for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa.</description><Author>Jan J. Jobsen, Lambert Naudin ten Cate, Marnix L. M. Lybeert, Astrid Scholten, Elzbieta M. van der Steen-Banasik, Job van der Palen, Marika C. Stenfert Kroese, Annerie Slot, Eltjo M. J. Schutter, and Sabine Siesling</Author><copyright>Copyright &amp;#xa9; 2011 Jan J. Jobsen et al. All rights reserved.</copyright></item><item><title>Silent Uterine Rupture with the Use of Misoprostol for Second Trimester Termination of Pregnancy : A Case Report</title><link>http://www.hindawi.com/journals/ogi/2011/584652/</link><description>Uterine rupture is an uncommon, but a life-threatening, complication following second trimester medical termination of pregnancy (TOP). The reported cases have been in both the scarred and unscarred uterus (Rajesh et al. 2002, Drey et al. 2006, and Dickinson). A  27-year-old with two previous deliveries, no previous caesarean section, no history of induced abortions, and no gynaecological operations. She presented with amenorrhoea, and according to her last normal menstruation, she was 10 weeks and 5 days. Ultrasound was done, and it reported 16 weeks and 5 days. She asked for TOP. According to the clinic&amp;#39;s protocol, misoprostol 800&amp;#x2009;mcg (4 tabs) were given to be used vaginally as a loading dose and another three to be taken orally after that. In the following day when she attended the clinic for follow up, a manual vacuum aspiration (MVA). A manual vacuum aspiration was indicated as an incomplete abortion. During the procedure, a uterine rupture was found in the uterine lower segment. A laparotomy was done and a lineal uterine rupture was found and sutured. The patient had a good postoperative recovery and was discharged from hospital after four days. The clinician dealing with second trimester terminations should be aware of the possibility of having a uterine rupture, especially in patients with a uterine scar in order to make an early diagnosis.</description><Author>Martin Cuellar Torriente</Author><copyright>Copyright &amp;#xa9; 2011 Martin Cuellar Torriente. All rights reserved.</copyright></item><item><title>Gonadal Dysgenesis 46, XX Associated with Mayer-Rokitansky-Kuster-Hauser Syndrome: One Case Report</title><link>http://www.hindawi.com/journals/ogi/2010/847370/</link><description>Introduction. The association of gonadal dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome is very rare and appears to be coincidental, independent of chromosomal anomalies. Case Report. We report the case of a 19-year-old woman who presented primary amenorrhea and impuberism. The endocrine study  revealed hypergonadotrophic hypogonadism. The karyotype was normal, 46XX. No chromosome Y was detected at the FISH analysis. Internal genitalia could not be identified on the pelvic ultrasound and pelvic MRI. Laparoscopy was undertaken and revealed concomitant ovarian dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome. There were no other morphological malformations. Conclusion. The pathogenesis of the association of gonadal dysgenesis and Mayer Rokitansky kuster hauser syndrome is still mysterious. The treatment is based essentially on hormone substitution therapy. The fertility prognosis is unfortunately compromised.</description><Author>N. Bousfiha, S. Errarhay, H. Saadi, K. Ouldim, C. Bouchikhi, and A. Banani</Author><copyright>Copyright &amp;#xa9; 2010 N. Bousfiha et al. All rights reserved.</copyright></item><item><title>Birth Weight in Type 1 Diabetic Pregnancy</title><link>http://www.hindawi.com/journals/ogi/2010/397623/</link><description>Our aim was to investigate whether birth weight in mothers with diabetes mellitus type 1 is higher as compared to nondiabetic controls. Methods. A retrospective study was performed using an existing database covering the region of Flanders, Belgium. Data included the presence of diabetes type 1, hypertension, parity, maternal age, the use  artificial reproductive technology, fetal- neonatal death, congenital anomalies, admission to a neonatal intensive care unit, and delivery by Caesarean section or vaginally. Results. In the period studied, 354 women with diabetes type 1 gave birth and were compared with 177.471 controls. Women with type 1 diabetes more often had a maternal age of over 35 years (16.7&amp;#37; versus 12.0&amp;#37;, P=.008, OR 1.46; 95&amp;#37; CI 1.09&amp;#8211;1.95). They more frequently suffered hypertension in pregnancy (19.5&amp;#37; versus 4.7&amp;#37;, P&amp;#x003C;.0001, OR 4.91; 95&amp;#37; CI 3.73&amp;#8211;6.44). Perinatal death was significantly higher in the diabetes mellitus group (3.05&amp;#37; versus 0.73&amp;#37;, P&amp;#x003C;.0001, OR 4.28; 95&amp;#37; CI 2.22&amp;#8211;8.01). Caesarean section was performed almost 5 times as frequently in the diabetes versus the control group (OR 4.57; 95&amp;#37; CI 3.70&amp;#8211;5.65).
  Birth weight was significantly higher in diabetic pregnant women from 33 until 38 weeks included, but those reaching 39 weeks and later were not different with control groups. Conclusion. In Belgium, diabetic pregnancy still carries a high risk for fetal and maternal complications; in general birth weight is significantly higher but for those reaching term there is no significant difference in birth weight.</description><Author>Jacquemyn Yves, Vandermotte Valerie, Van Hoorick Katrien, and Martens Guy</Author><copyright>Copyright &amp;#xa9; 2010 Jacquemyn Yves et al. All rights reserved.</copyright></item><item><title>Klippel-Trenaunay Syndrome and Pregnancy</title><link>http://www.hindawi.com/journals/ogi/2010/706850/</link><description>Klippel-Trenaunay syndrome is a rare congenital vascular disorder, and only few cases have been described in pregnancy. We describe two cases, in one patient without complications, the other patient developed postpartum deep venous thrombosis.</description><Author>Tu&amp;#287;ba G&amp;#252;ngor G&amp;#252;ndo&amp;#287;an and Y. Jacquemyn</Author><copyright>Copyright &amp;#xa9; 2010 G&amp;#xfc;ndor G&amp;#xfc;ndogan Tugba and Y. Jacquemyn. All rights reserved.</copyright></item><item><title>Postpartum Pneumomediastinum: An Uncommon Cause for Chest Pain</title><link>http://www.hindawi.com/journals/ogi/2010/956142/</link><description>This case report refers to a 32-year-old primiparous woman with a mild asthma, who had a normal vaginal delivery in a birthing pool and developed an acute postpartum chest pain due to pneumomediastinum and subcutaneous chest emphysema. After 72 hours of observation, she was discharged home without any residual symptoms.</description><Author>Vladimir Revicky, Paul Simpson, and David Fraser</Author><copyright>Copyright &amp;#x00A9; 2010 Vladimir Revicky et al. All rights reserved.</copyright></item><item><title>The Possible Role of Epigenetics in Gestational Diabetes:  Cause, Consequence, or Both</title><link>http://www.hindawi.com/journals/ogi/2010/605163/</link><description>Gestational diabetes mellitus (GDM) is defined as the glucose intolerance that is not present or recognized prior to pregnancy. Several risk factors of GDM depend on environmental factors that are thought to regulate the genome through epigenetic mechanisms. Thus, epigenetic regulation could be involved in the development of GDM. In addition, the adverse intrauterine environment in patients with GDM could also have a negative impact on the establishment of the epigenomes of the offspring.</description><Author>J. L. Fern&amp;#225;ndez-Morera, S. Rodr&amp;#237;guez-Rodero, E. Men&amp;#233;ndez-Torre, and M. F. Fraga</Author><copyright>Copyright &amp;#xa9; 2010 J. L. Fern&amp;#xe1;ndez-Morera et al. All rights reserved.</copyright></item></channel></rss>
